George Frey, MD, is also Aclarion’s first key opinion leader to onboard Nociscan to a hospital MRI. The software leverages augmented intelligence.
“Treating patients effectively starts with an informed understanding of where their pain is coming from,” Dr. Frey said in the release. “In my experience with Nociscan, objectively measuring the biomarker content corelated with pain within a disc that may look healthy on an MRI, adds to my knowledge of how to treat that patient.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
